Location
United States, North America
Cheque size
$500K - $15M
Investment Stage
Seed
Series A
Focus Areas
AI
BioTech
Pharmaceuticals
About Investor
Michael Nally serves as CEO-Partner at Flagship Pioneering and Chief Executive Officer of Generate:Biomedicines, focusing on investments ranging from $500K to $15.0M in Pharmaceuticals, BioTech, and AI companies at seed and Series A stages. His geographic focus is Boston/New England. Nally joined Flagship in 2021 and brings extensive experience in leading global pharmaceutical organizations with a deep commitment to innovation and patient care.
Previous investments
Generate Biomedicines
270M |2023
370M |2021
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.